Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Han K, Zou J, Zhao Z, Baskurt Z, Zheng Y, Barnes E, Croke J, Ferguson SE, Fyles A, Gien L, Gladwish A, Lecavalier-Barsoum M, Lheureux S, Lukovic J, Mackay H, Marchand EL, Metser U, Milosevic M, Taggar AS, Bratman SV, Leung E. Clinical Validation of Human Papilloma Virus Circulating Tumor DNA for Early Detection of Residual Disease After Chemoradiation in Cervical Cancer. J Clin Oncol. 2024 Feb 1;42(4):431-440. doi: 10.1200/JCO.23.00954. Epub 2023 Nov 16. PubMed PMID: 37972346; PubMed Central PMCID: PMC10824379.
Murphy T, Zou J, Arruda A, Wang TT, Zhao Z, Zheng Y, Gupta V, Maze D, McNamara C, Minden MD, Schimmer A, Sibai H, Yee K, Capo-Chichi JM, Stockley T, Schuh A, Bratman SV, Chan SM. Exclusion of persistent mutations in splicing factor genes and isocitrate dehydrogenase 2 improves the prognostic power of molecular measurable residual disease assessment in acute myeloid leukemia. Haematologica. 2024 Feb 1;109(2):671-675. doi: 10.3324/haematol.2023.283510. PubMed PMID: 37345484; PubMed Central PMCID: PMC10828788.
Hope A, Kim JW, Kazmierski M, Welch M, Marsilla J, Huang SH, Hosni A, Tadic T, Patel T, Haibe-Kains B, Waldron J, O'Sullivan B, Bratman S. The Auto-Lindberg Project: Standardized Target Nomenclature in Radiation Oncology Enables Real-World Data Extraction From Radiation Treatment Plans. Int J Radiat Oncol Biol Phys. 2024 Jan 1;118(1):268-274. doi: 10.1016/j.ijrobp.2023.08.018. Epub 2023 Aug 21. PubMed PMID: 37611810.
Watson E, El Maghrabi A, Lee JH, Pu J, Xu W, Joudah S, D'Souza V, Quiñonez C, Mojdami ZD, Huang SH, O'Sullivan B, Ringash J, Kim J, Cho J, Bratman S, Waldron J, Goldstein D, Abdalaty AH, Glogauer M, Hope A. Implication of dental insurance status on patterns of pre-radiation dental extraction and risk of osteoradionecrosis of the jaw in head-and-neck cancer patients. Oral Oncol. 2023 Oct;145:106527. doi: 10.1016/j.oraloncology.2023.106527. Epub 2023 Jul 25. PubMed PMID: 37499325.
Zeng Y, Ye W, Stutheit-Zhao EY, Han M, Bratman SV, Pugh TJ, He HH. MEDIPIPE: an automated and comprehensive pipeline for cfMeDIP-seq data quality control and analysis. Bioinformatics. 2023 Jul 1;39(7). doi: 10.1093/bioinformatics/btad423. PubMed PMID: 37402621; PubMed Central PMCID: PMC10348834.
Taylor K, Zou J, Magalhaes M, Oliva M, Spreafico A, Hansen AR, McDade SS, Coyle VM, Lawler M, Elimova E, Bratman SV, Siu LL. Circulating tumour DNA kinetics in recurrent/metastatic head and neck squamous cell cancer patients. Eur J Cancer. 2023 Jul;188:29-38. doi: 10.1016/j.ejca.2023.04.014. Epub 2023 Apr 20. PubMed PMID: 37182343.
Kim JW, Marsilla J, Kazmierski M, Tkachuk D, Huang SH, Xu W, Cho J, Ringash J, Bratman S, Haibe-Kains B, Hope A. Effect of Radiation Therapy Quality Assurance on Nasopharyngeal Carcinoma: Usage of a Novel, Web-Based Quality Assurance Application. Pract Radiat Oncol. 2023 Jul-Aug;13(4):e354-e364. doi: 10.1016/j.prro.2023.03.003. Epub 2023 Mar 21. PubMed PMID: 36948414.
Kazmierski M, Welch M, Kim S, McIntosh C, Rey-McIntyre K, Huang SH, Patel T, Tadic T, Milosevic M, Liu FF, Ryczkowski A, Kazmierska J, Ye Z, Plana D, Aerts HJWL, Kann BH, Bratman SV, Hope AJ, Haibe-Kains B. Multi-institutional Prognostic Modeling in Head and Neck Cancer: Evaluating Impact and Generalizability of Deep Learning and Radiomics. Cancer Res Commun. 2023 Jun;3(6):1140-1151. doi: 10.1158/2767-9764.CRC-22-0152. eCollection 2023 Jun. PubMed PMID: 37397861; PubMed Central PMCID: PMC10309070.
Karimzadeh M, Arlidge C, Rostami A, Lupien M, Bratman SV, Hoffman MM. Human papillomavirus integration transforms chromatin to drive oncogenesis. Genome Biol. 2023 Jun 27;24(1):142. doi: 10.1186/s13059-023-02926-9. PubMed PMID: 37365652; PubMed Central PMCID: PMC10294493.
Brooks PJ, Malkin EZ, De Michino S, Bratman SV. Isolation of salivary cell-free DNA for cancer detection. PLoS One. 2023;18(5):e0285214. doi: 10.1371/journal.pone.0285214. eCollection 2023. PubMed PMID: 37130100; PubMed Central PMCID: PMC10153704.
Ballal Y, Gete M, Su J, O'Sullivan B, Waldron JN, Irish J, Ringash J, Kim J, Bratman S, Cho J, Hope AJ, Hosni A, de Almeida J, Goldstein DP, Witterick I, Monteiro E, Tong L, Xu W, Hui Huang S, Hahn E. The collateral impact of the COVID-19 pandemic on HPV-positive oropharyngeal cancer diagnosis. Oral Oncol. 2023 Mar;138:106332. doi: 10.1016/j.oraloncology.2023.106332. Epub 2023 Feb 3. PubMed PMID: 36780824; PubMed Central PMCID: PMC9894773.
Ul Haq S, Schmid S, Aparnathi MK, Hueniken K, Zhan LJ, Sacdalan D, Li JJN, Meti N, Patel D, Cheng D, Philip V, Tsao MS, Cabanero M, de Carvalho D, Liu G, Bratman SV, Lok BH. Cell-free DNA methylation-defined prognostic subgroups in small-cell lung cancer identified by leukocyte methylation subtraction. iScience. 2022 Dec 22;25(12):105487. doi: 10.1016/j.isci.2022.105487. eCollection 2022 Dec 22. PubMed PMID: 36425756; PubMed Central PMCID: PMC9678731.
Chen S, Petricca J, Ye W, Guan J, Zeng Y, Cheng N, Gong L, Shen SY, Hua JT, Crumbaker M, Fraser M, Liu S, Bratman SV, van der Kwast T, Pugh T, Joshua AM, De Carvalho DD, Chi KN, Awadalla P, Ji G, Feng F, Wyatt AW, He HH. The cell-free DNA methylome captures distinctions between localized and metastatic prostate tumors. Nat Commun. 2022 Oct 29;13(1):6467. doi: 10.1038/s41467-022-34012-2. PubMed PMID: 36309516; PubMed Central PMCID: PMC9617856.
Malkin EZ, De Michino S, Lambie M, Gill R, Zhao Z, Rostami A, Arruda A, Minden MD, Bratman SV. Cell-free DNA topology depends on its subcellular and cellular origins in cancer. JCI Insight. 2022 Oct 24;7(20). doi: 10.1172/jci.insight.159590. PubMed PMID: 36125881; PubMed Central PMCID: PMC9714790.
Ghatasheh H, Huang SH, Su J, Xu W, Bratman SV, Cho J, Giuliani M, Hahn E, Hope A, Kim J, O'Sullivan B, Ringash J, Waldron J, Chepeha DB, Irish JC, Goldstein DP, Spreafico A, Tong L, de Almeida JR, Hosni A. Evaluation of risk-tailored individualized selection of radiation therapy target volume for head and neck carcinoma of unknown primary. Radiother Oncol. 2022 Oct;175:56-64. doi: 10.1016/j.radonc.2022.07.016. Epub 2022 Jul 26. PubMed PMID: 35905781.
Haddad G, Hueniken K, Xu MC, Bratman S, de Almeida J, Goldstein D, Huang SH, Hansen A, Hope A, Spreafico A, Xu W, Liu G. Association of post-treatment longitudinal symptom severity clusters with subsequent survival in oropharyngeal cancer. Head Neck. 2022 Oct;44(10):2181-2196. doi: 10.1002/hed.27139. Epub 2022 Jul 7. PubMed PMID: 35801270.
Wilson SL, Shen SY, Harmon L, Burgener JM, Triche T Jr, Bratman SV, De Carvalho DD, Hoffman MM. Sensitive and reproducible cell-free methylome quantification with synthetic spike-in controls. Cell Rep Methods. 2022 Sep 19;2(9):100294. doi: 10.1016/j.crmeth.2022.100294. eCollection 2022 Sep 19. PubMed PMID: 36160046; PubMed Central PMCID: PMC9499995.
Huang SH, Jacinto JCK, O'Sullivan B, Su J, Kim J, Ringash J, Spreafico A, Yu E, Perez-Ordonez B, Weinreb I, Cho J, Hope AJ, Bratman SV, Giuliani ME, Hosni A, Hahn E, Goldstein DP, Tong L, Eng L, Xu W, Waldron JN. Clinical presentation and outcome of human papillomavirus-positive nasopharyngeal carcinoma in a North American cohort. Cancer. 2022 Aug 1;128(15):2908-2921. doi: 10.1002/cncr.34266. Epub 2022 May 19. PubMed PMID: 35588085.
Dmytriw AA, Ortega C, Anconina R, Metser U, Liu ZA, Liu Z, Li X, Sananmuang T, Yu E, Joshi S, Waldron J, Huang SH, Bratman S, Hope A, Veit-Haibach P. Nasopharyngeal Carcinoma Radiomic Evaluation with Serial PET/CT: Exploring Features Predictive of Survival in Patients with Long-Term Follow-Up. Cancers (Basel). 2022 Jun 24;14(13). doi: 10.3390/cancers14133105. PubMed PMID: 35804877; PubMed Central PMCID: PMC9264840.
Main SC, Cescon DW, Bratman SV. Liquid biopsies to predict CDK4/6 inhibitor efficacy and resistance in breast cancer. Cancer Drug Resist. 2022;5(3):727-748. doi: 10.20517/cdr.2022.37. eCollection 2022. Review. PubMed PMID: 36176758; PubMed Central PMCID: PMC9511796.
Lassen P, Huang SH, Su J, Waldron J, Andersen M, Primdahl H, Johansen J, Kristensen CA, Andersen E, Eriksen JG, Hansen CR, Alsner J, Lilja-Fisher J, Bratman SV, Ringash J, Kim J, Hope A, Spreafico A, de Almeida J, Xu W, O'Sullivan B, Overgaard J. Treatment outcomes and survival following definitive (chemo)radiotherapy in HPV-positive oropharynx cancer: Large-scale comparison of DAHANCA vs PMH cohorts. Int J Cancer. 2022 Apr 15;150(8):1329-1340. doi: 10.1002/ijc.33876. Epub 2021 Dec 2. PubMed PMID: 34792199.
Id Said B, Ailles L, Karamboulas C, Meens J, Huang SH, Xu W, Keshavarzi S, Bratman SV, Cho BCJ, Giuliani M, Hahn E, Kim J, O'Sullivan B, Ringash J, Waldron J, Spreafico A, de Almeida JR, Chepeha DB, Irish JC, Goldstein DP, Hope A, Hosni A. Development and Validation of an Oral Cavity Cancer Outcomes Prediction Score Incorporating Patient-Derived Xenograft Engraftment. JAMA Otolaryngol Head Neck Surg. 2022 Apr 1;148(4):342-349. doi: 10.1001/jamaoto.2022.0003. PubMed PMID: 35238880; PubMed Central PMCID: PMC8895316.
Ren J, Pang W, Hueniken K, Haddad G, Hope A, Huang SH, Spreafico A, Hansen AR, Perez-Ordonez B, Goldstein DP, Bratman SV, Zhang W, Zhao Y, Xu W, de Almeida JR, Liu G. Longitudinal health utility and symptom-toxicity trajectories in patients with head and neck cancers. Cancer. 2022 Feb 1;128(3):497-508. doi: 10.1002/cncr.33936. Epub 2021 Oct 1. PubMed PMID: 34597435.
Sanz-Garcia E, Zhao E, Bratman SV, Siu LL. Monitoring and adapting cancer treatment using circulating tumor DNA kinetics: Current research, opportunities, and challenges. Sci Adv. 2022 Jan 28;8(4):eabi8618. doi: 10.1126/sciadv.abi8618. Epub 2022 Jan 26. Review. PubMed PMID: 35080978; PubMed Central PMCID: PMC8791609.
Chin O, Yu E, O'Sullivan B, Su J, Tellier A, Siu L, Waldron J, Kim J, Hansen A, Hope A, Cho J, Giuliani M, Ringash J, Spreafico A, Bratman S, Hosni A, Hahn E, Tong L, Xu W, Huang SH. Prognostic importance of radiologic extranodal extension in nasopharyngeal carcinoma treated in a Canadian cohort. Radiother Oncol. 2021 Dec;165:94-102. doi: 10.1016/j.radonc.2021.10.018. Epub 2021 Oct 27. PubMed PMID: 34718052.
Zazuli Z, de Jong C, Xu W, Vijverberg SJH, Masereeuw R, Patel D, Mirshams M, Khan K, Cheng D, Ordonez-Perez B, Huang S, Spreafico A, Hansen AR, Goldstein DP, de Almeida JR, Bratman SV, Hope A, Knox JJ, Wong RKS, Darling GE, Kitchlu A, van Haarlem SWA, van der Meer F, van Lindert ASR, Ten Heuvel A, Brouwer J, Ross CJD, Carleton BC, Egberts TCG, Herder GJM, Deneer VHM, Maitland-van der Zee AH, Liu G. Association between Genetic Variants and Cisplatin-Induced Nephrotoxicity: A Genome-Wide Approach and Validation Study. J Pers Med. 2021 Nov 20;11(11). doi: 10.3390/jpm11111233. PubMed PMID: 34834585; PubMed Central PMCID: PMC8623115.
Leung E, Han K, Zou J, Zhao Z, Zheng Y, Wang TT, Rostami A, Siu LL, Pugh TJ, Bratman SV. HPV Sequencing Facilitates Ultrasensitive Detection of HPV Circulating Tumor DNA. Clin Cancer Res. 2021 Nov 1;27(21):5857-5868. doi: 10.1158/1078-0432.CCR-19-2384. Epub 2021 Sep 27. PubMed PMID: 34580115; PubMed Central PMCID: PMC9401563.
Muhanna N, Eu D, Chan HHL, Douglas C, Townson JL, Di Grappa MA, Mohamadi RM, Kelley SO, Bratman SV, Irish JC. Cell-free DNA and circulating tumor cell kinetics in a pre-clinical head and neck Cancer model undergoing radiation therapy. BMC Cancer. 2021 Oct 2;21(1):1075. doi: 10.1186/s12885-021-08791-8. PubMed PMID: 34600526; PubMed Central PMCID: PMC8487588.
Chiu K, Hosni A, Huang SH, Tong L, Xu W, Lu L, Bayley A, Bratman S, Cho J, Giuliani M, Kim J, Ringash J, Waldron J, Spreafico A, Irish J, Gilbert R, Gullane P, Goldstein D, O'Sullivan B, Hope A. The Potential Impact and Usability of the Eighth Edition TNM Staging Classification in Oral Cavity Cancer. Clin Oncol (R Coll Radiol). 2021 Oct;33(10):e442-e449. doi: 10.1016/j.clon.2021.05.007. Epub 2021 Jul 11. PubMed PMID: 34261594.
Oliva M, Chepeha D, Araujo DV, Diaz-Mejia JJ, Olson P, Prawira A, Spreafico A, Bratman SV, Shek T, de Almeida J, R Hansen A, Hope A, Goldstein D, Weinreb I, Smith S, Perez-Ordoñez B, Irish J, Torti D, Bruce JP, Wang BX, Fortuna A, Pugh TJ, Der-Torossian H, Shazer R, Attanasio N, Au Q, Tin A, Feeney J, Sethi H, Aleshin A, Chen I, Siu L. Antitumor immune effects of preoperative sitravatinib and nivolumab in oral cavity cancer: SNOW window-of-opportunity study. J Immunother Cancer. 2021 Oct;9(10). doi: 10.1136/jitc-2021-003476. PubMed PMID: 34599023; PubMed Central PMCID: PMC8488751.
Rostami A, Bratman SV, Han K. Liquid Biopsy Goes Viral: Next-Generation Sequencing to Enhance HPV Detection. Clin Cancer Res. 2021 Oct 1;27(19):5158-5160. doi: 10.1158/1078-0432.CCR-21-2180. PubMed PMID: 34301747.
Gudi S, O'Sullivan B, Hosni A, Su J, Hope A, Ringash J, Hueniken K, Liu G, Tong L, Goldstein D, de Almeida J, Hansen AR, Bratman SV, Cho J, Giuliani M, Hahn E, Kim J, Xu W, Waldron J, Huang SH. Outcome and treatment toxicity in east-indian versus white-canadian patients with oral cavity cancer following postoperative (chemo-)radiotherapy delivered under similar multidisciplinary care: A propensity-matched cohort study. Oral Oncol. 2021 Sep;120:105419. doi: 10.1016/j.oraloncology.2021.105419. Epub 2021 Jun 25. PubMed PMID: 34175612.
Cindy Yang SY, Lien SC, Wang BX, Clouthier DL, Hanna Y, Cirlan I, Zhu K, Bruce JP, El Ghamrasni S, Iafolla MAJ, Oliva M, Hansen AR, Spreafico A, Bedard PL, Lheureux S, Razak A, Speers V, Berman HK, Aleshin A, Haibe-Kains B, Brooks DG, McGaha TL, Butler MO, Bratman SV, Ohashi PS, Siu LL, Pugh TJ. Pan-cancer analysis of longitudinal metastatic tumors reveals genomic alterations and immune landscape dynamics associated with pembrolizumab sensitivity. Nat Commun. 2021 Aug 26;12(1):5137. doi: 10.1038/s41467-021-25432-7. PubMed PMID: 34446728; PubMed Central PMCID: PMC8390680.
Burgener JM, Zou J, Zhao Z, Zheng Y, Shen SY, Huang SH, Keshavarzi S, Xu W, Liu FF, Liu G, Waldron JN, Weinreb I, Spreafico A, Siu LL, de Almeida JR, Goldstein DP, Hoffman MM, De Carvalho DD, Bratman SV. Tumor-Naïve Multimodal Profiling of Circulating Tumor DNA in Head and Neck Squamous Cell Carcinoma. Clin Cancer Res. 2021 Aug 1;27(15):4230-4244. doi: 10.1158/1078-0432.CCR-21-0110. Epub 2021 Jun 22. PubMed PMID: 34158359; PubMed Central PMCID: PMC9401560.
Reiazi R, Abbas E, Famiyeh P, Rezaie A, Kwan JYY, Patel T, Bratman SV, Tadic T, Liu FF, Haibe-Kains B. The impact of the variation of imaging parameters on the robustness of Computed Tomography radiomic features: A review. Comput Biol Med. 2021 Jun;133:104400. doi: 10.1016/j.compbiomed.2021.104400. Epub 2021 Apr 16. Review. PubMed PMID: 33930766.
Reiazi R, Arrowsmith C, Welch M, Abbas-Aghababazadeh F, Eeles C, Tadic T, Hope AJ, Bratman SV, Haibe-Kains B. Prediction of Human Papillomavirus (HPV) Association of Oropharyngeal Cancer (OPC) Using Radiomics: The Impact of the Variation of CT Scanner. Cancers (Basel). 2021 May 8;13(9). doi: 10.3390/cancers13092269. PubMed PMID: 34066857; PubMed Central PMCID: PMC8125906.
Arrowsmith C, Reiazi R, Welch ML, Kazmierski M, Patel T, Rezaie A, Tadic T, Bratman S, Haibe-Kains B. Automated detection of dental artifacts for large-scale radiomic analysis in radiation oncology. Phys Imaging Radiat Oncol. 2021 Apr;18:41-47. doi: 10.1016/j.phro.2021.04.001. eCollection 2021 Apr. PubMed PMID: 34258406; PubMed Central PMCID: PMC8254196.
Sananmuang T, Yu E, Su J, O'Sullivan B, Rathod S, Chan B, Bartlett E, Waldron J, Ringash J, Kim J, Bratman SV, Hope A, Spreafico A, Hansen AR, de Almeida J, Goldstein DP, Witterick I, Tong L, Xu W, Huang SH. Pre- and Post-Radiotherapy Radiologic Nodal Features and Oropharyngeal Cancer Outcomes. Laryngoscope. 2021 Apr;131(4):E1162-E1171. doi: 10.1002/lary.29045. Epub 2020 Oct 1. PubMed PMID: 33002201.
Oliva M, Schneeberger PHH, Rey V, Cho M, Taylor R, Hansen AR, Taylor K, Hosni A, Bayley A, Hope AJ, Bratman SV, Ringash J, Singh S, Weinreb I, Perez-Ordoñez B, Chepeha D, Waldron J, Xu W, Guttman D, Siu LL, Coburn B, Spreafico A. Transitions in oral and gut microbiome of HPV+ oropharyngeal squamous cell carcinoma following definitive chemoradiotherapy (ROMA LA-OPSCC study). Br J Cancer. 2021 Apr;124(9):1543-1551. doi: 10.1038/s41416-020-01253-1. Epub 2021 Mar 10. PubMed PMID: 33750907; PubMed Central PMCID: PMC8076306.
Wong ET, Huang SH, O'Sullivan B, Persaud V, Su J, Waldron J, Goldstein DP, de Almeida J, Ringash J, Kim J, Hope A, Bratman S, Cho J, Giuliani M, Hosni A, Spreafico A, Hansen A, Tong L, Xu W, Yu E. Head and neck imaging surveillance strategy for HPV-positive oropharyngeal carcinoma following definitive (chemo)radiotherapy. Radiother Oncol. 2021 Apr;157:255-262. doi: 10.1016/j.radonc.2021.02.005. Epub 2021 Feb 16. PubMed PMID: 33600871.
de Almeida JR, Seungyeon Kim V, O'Sullivan B, Goldstein DP, Bratman SV, Hui Huang S, Su J, Xu W, Parulekar W, Waldron JN, Hosni A. Comparing unilateral vs. bilateral neck management in lateralized oropharyngeal cancer between surgical and radiation oncologists: An international practice pattern survey. Oral Oncol. 2021 Mar;114:105165. doi: 10.1016/j.oraloncology.2020.105165. Epub 2021 Jan 30. PubMed PMID: 33524796.
Pilar A, Yu E, Su J, O'Sullivan B, Bartlett E, Waldron JN, Ringash J, Spreafico A, Hansen AR, de Almeida J, Bayley A, Bratman SV, Cho J, Giuliani M, Hope A, Hosni A, Kim J, Tong L, Xu W, Huang SH. Prognostic value of clinical and radiologic extranodal extension and their role in the 8th edition TNM cN classification for HPV-negative oropharyngeal carcinoma. Oral Oncol. 2021 Mar;114:105167. doi: 10.1016/j.oraloncology.2020.105167. Epub 2021 Jan 25. PubMed PMID: 33508706.
Huang SH, de Almeida JR, Watson E, Glogauer M, Xu W, Keshavarzi S, O'Sullivan B, Ringash J, Hope A, Bayley A, Bratman SV, Cho J, Giuliani M, Kim J, Waldron J, Spreafico A, Goldstein DP, Chepeha DB, Li T, Hosni A. Short-term and long-term unstimulated saliva flow following unilateral vs bilateral radiotherapy for oropharyngeal carcinoma. Head Neck. 2021 Feb;43(2):456-466. doi: 10.1002/hed.26496. Epub 2020 Oct 15. Review. PubMed PMID: 33058305.
Hosni A, Chiu K, Huang SH, Xu W, Huang J, Bayley A, Bratman SV, Cho J, Giuliani M, Kim J, O'Sullivan B, Ringash J, Waldron J, Spreafico A, de Almeida JR, Monteiro E, Witterick I, Chepeha DB, Gilbert RW, Irish JC, Goldstein DP, Hope A. Non-operative management for oral cavity carcinoma: Definitive radiation therapy as a potential alternative treatment approach. Radiother Oncol. 2021 Jan;154:70-75. doi: 10.1016/j.radonc.2020.08.013. Epub 2020 Aug 28. PubMed PMID: 32861702; PubMed Central PMCID: PMC7453211.
Sanduleanu S, Jochems A, Upadhaya T, Even AJG, Leijenaar RTH, Dankers FJWM, Klaassen R, Woodruff HC, Hatt M, Kaanders HJAM, Hamming-Vrieze O, van Laarhoven HWM, Subramiam RM, Huang SH, O'Sullivan B, Bratman SV, Dubois LJ, Miclea RL, Di Perri D, Geets X, Crispin-Ortuzar M, Apte A, Deasy JO, Oh JH, Lee NY, Humm JL, Schöder H, De Ruysscher D, Hoebers F, Lambin P. Non-invasive imaging prediction of tumor hypoxia: A novel developed and externally validated CT and FDG-PET-based radiomic signatures. Radiother Oncol. 2020 Dec;153:97-105. doi: 10.1016/j.radonc.2020.10.016. Epub 2020 Nov 1. PubMed PMID: 33137396.
Zhao EY, Bratman SV. Emerging Precision Oncology Applications of Liquid Biopsy using Circulating Tumour DNA and Methylome Profiling. Clin Oncol (R Coll Radiol). 2020 Oct;32(10):626-631. doi: 10.1016/j.clon.2020.05.022. Epub 2020 Jun 23. PubMed PMID: 32586654.
Shi W, Misra S, Li M, Su J, Chong LP, McCuske M, Williams J, Xu W, Ghoraie LS, Sutherland DR, Han K, Minden MD, Bratman SV, Yip KW, Liu FF. Inflammatory Biomarkers, Hematopoietic Stem Cells, and Symptoms in Breast Cancer Patients Undergoing Adjuvant Radiation Therapy. JNCI Cancer Spectr. 2020 Oct;4(5):pkaa037. doi: 10.1093/jncics/pkaa037. eCollection 2020 Oct. PubMed PMID: 33134822; PubMed Central PMCID: PMC7583146.
Schmid S, Stewart EL, Martins-Filho SN, Cabanero M, Wang A, Bao H, Wu X, Patel D, Chen Z, Law JH, Bradbury PA, Shepherd FA, Leighl N, Tsao MS, Pugh T, Bratman SV, Sacher A, Liu G. Early Detection of Multiple Resistance Mechanisms by ctDNA Profiling in a Patient With EGFR-mutant Lung Adenocarcinoma Treated With Osimertinib. Clin Lung Cancer. 2020 Sep;21(5):e488-e492. doi: 10.1016/j.cllc.2020.03.009. Epub 2020 Apr 9. PubMed PMID: 32389504.
Day D, Prawira A, Spreafico A, Waldron J, Karithanam R, Giuliani M, Weinreb I, Kim J, Cho J, Hope A, Bayley A, Ringash J, Bratman SV, Jang R, O'Sullivan B, Siu LL, Hansen AR. Phase I trial of alpelisib in combination with concurrent cisplatin-based chemoradiotherapy in patients with locoregionally advanced squamous cell carcinoma of the head and neck. Oral Oncol. 2020 Sep;108:104753. doi: 10.1016/j.oraloncology.2020.104753. Epub 2020 May 25. PubMed PMID: 32464516.
De Michino S, Aparnathi M, Rostami A, Lok BH, Bratman SV. The Utility of Liquid Biopsies in Radiation Oncology. Int J Radiat Oncol Biol Phys. 2020 Aug 1;107(5):873-886. doi: 10.1016/j.ijrobp.2020.05.008. Epub 2020 May 14. Review. PubMed PMID: 32417410.
What would you like to do?